Evidence map›Paper›PMID 37965640›Full record

ArticleOpen forum infectious diseases2023

Clinical and Metagenomic Characterization of Neurological Infections of People With Human Immunodeficiency Virus in the Peruvian Amazon.

Hannah E Steinberg, Prashanth S Ramachandran, Andrea Diestra, Lynn Pinchi, Cusi Ferradas, Daniela E Kirwan, Monica M Diaz, Michael Sciaudone, Annie Wapniarski, Kelsey C Zorn and 8 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 citations in OpenAlex.

  1. Seroprevalence of IgG Antibodies AgainstPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 4 countries.

Hannah E SteinbergDepartment of Microbiology and Immunology, University of Illinois Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-3841-6154
Prashanth S RamachandranDepartment of Infectious Diseases, The Peter Doherty Institute for Immunity and Infection, University of Melbourne, Melbourne, Australia.
Andrea DiestraLaboratorio de Investigación en Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru.
Lynn PinchiAsociación Benéfica Prisma, Lima, Peru.
Cusi FerradasEmerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.
Daniela E KirwanInstitute for Infection and Immunity, St George's, University of London, London, United Kingdom.
Monica M DiazDepartment of Neurology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Michael SciaudoneDivision of Infectious Diseases, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Annie WapniarskiWeill Institute for Neurosciences, Department of Neurology, University of California, SanFrancisco, San Francisco, California, USA.
Kelsey C ZornWeill Institute for Neurosciences, Department of Neurology, University of California, SanFrancisco, San Francisco, California, USA.
Maritza CalderónLaboratorio de Investigación en Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru.
Lilia CabreraAsociación Benéfica Prisma, Lima, Peru.
Viviana Pinedo-CancinoLaboratorio de Investigación de Productos Naturales Antiparasitarios de la Amazonía, Centro de Investigación de Recursos Naturales, Universidad Nacional de la Amazonía Peruana, Iquitos, Peru.
Michael R WilsonWeill Institute for Neurosciences, Department of Neurology, University of California, SanFrancisco, San Francisco, California, USA.
Cesar Ramal AsayagDepartment of Clinical Sciences, Universidad Nacional de la Amazonía Peruana, Iquitos, Peru.
Robert H GilmanDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Natalie M BowmanDivision of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Toxoplasmosis Working Group in Peru
Universidad Nacional de la Amazonía Peruana · PEUniversidad Peruana Cayetano Heredia · PEUniversity of California, San Francisco · USPrisma · PEUniversity of North Carolina at Chapel Hill · USJohns Hopkins University · USSt George's, University of London · GBThe Royal Melbourne Hospital · AUTulane University · USUniversity of Illinois Chicago · US

Funding

Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin AmericaR01AI136722 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2018 to 2022
$3.3M
Medical Research Council MR/P019978/1Medical Research Council MR/P019978/2NIAID NIH HHS R01 AI136722
6 · The paper itself

Abstract

Background: Neurological opportunistic infections cause significant morbidity and mortality in people with human immunodeficiency virus (HIV) but are difficult to diagnose. Methods: One hundred forty people with HIV with acute neurological symptoms from Iquitos, Peru, were evaluated for cerebral toxoplasmosis with quantitative polymerase chain reaction (qPCR) of cerebrospinal fluid (CSF) and for cryptococcal meningitis with cryptococcal antigen test (CrAg) in serum or CSF. Differences between groups were assessed with standard statistical methods. A subset of samples was evaluated by metagenomic next-generation sequencing (mNGS) of CSF to compare standard diagnostics and identify additional diagnoses. Results: Twenty-seven participants were diagnosed with cerebral toxoplasmosis by qPCR and 13 with cryptococcal meningitis by CrAg. Compared to participants without cerebral toxoplasmosis, abnormal Glasgow Coma Scale score ( Conclusions: An infection was diagnosed by any method in only 34% of participants, demonstrating the challenges of diagnosing neurological opportunistic infections in this population and highlighting the need for broader, more sensitive diagnostic tests for central nervous system infections.

Identifiers

PMID37965640
PMCPMC10642733
OpenAlexW4388193854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.